Healthcare delivery for HIV-positive people with tuberculosis in Europe
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Dokumenter
- Fulltext
Accepteret manuskript, 518 KB, PDF-dokument
Background: In a 2013 survey, we reported distinct discrepancies in delivery of tuberculosis (TB) and HIV services in eastern Europe (EE) vs. western Europe (WE). Objectives: To verify the differences in TB and HIV services in EE vs. WE. Methods: Twenty-three sites completed a survey in 2018 (EE, 14; WE, nine; 88% response rate). Results were compared across as well as within the two regions. When possible, results were compared with the 2013 survey. Results: Delivery of healthcare was significantly less integrated in EE: provision of TB and HIV services at one site (36% in EE vs. 89% in WE; P = 0.034), and continued TB follow-up in one location (42% vs. 100%; P = 0.007). Although access to TB diagnostics, standard TB and HIV drugs was generally good, fewer sites in EE reported unlimited access to rifabutin/multi-drug-resistant TB (MDR-TB) drugs, HIV integrase inhibitors and opioid substitution therapy (OST). Compared with 2013, routine usage of GeneXpert was more common in EE in 2018 (54% vs. 92%; P = 0.073), as was access to moxifloxacin (46% vs. 91%; P = 0.033), linezolid (31% vs. 64%; P = 0.217), and bedaquiline (0% vs. 25%; P = 0.217). Integration of TB and HIV services (46% vs. 39%; P = 1.000) and provision of OST to patients with opioid dependency (54% vs. 46%; P = 0.695) remained unchanged. Conclusion: Delivery of TB and HIV healthcare, including integration of TB and HIV care and access to MDR-TB drugs, still differs between WE and EE, as well as between individual EE sites.
Originalsprog | Engelsk |
---|---|
Tidsskrift | HIV Medicine |
Vol/bind | 22 |
Udgave nummer | 4 |
Sider (fra-til) | 283-293 |
ISSN | 1464-2662 |
DOI | |
Status | Udgivet - 2021 |
Bibliografisk note
Funding Information:
Barcelona Cohort funded by the Spanish HIV/AIDS Research Network: Hospital Clinic of Barcelona: J.M. Miro (PI), C. Manzardo, C. Ligero and J. Gonzalez and Jose A. Martinez‐Martinez; Hospital del Mar: F. Sanchez, H. Knobel, M. Salvadó and J.L. Lopez‐Colomes; Mutua de Terrassa: X. Martínez‐Lacasa and E. Cuchí; Hospital Universitari Vall d’Hebrón: V. Falcó, A. Curran, M.T. Tortola, I. Ocaña and R. Vidal; Hospital Universitari de la Santa Creu i Sant Pau: M.A. Sambeat, V. Pomar and P. Coll; Hospital Universitari de Bellvitge: D. Pozamczer, M. Saumoy and F. Alcaide; Agencia de Salud Pública de Barcelona: J. Caylà, A. Moreno, J.P. Millet, A. Orcau, L. Fina, A. Romero, L.L. Roldan. Hospital Universitaria Donostia (San Sebastian): J.A. Iribarren (PI) and M. Ibarguren; Hospital Ramon y Cajal (Madrid): S. Moreno (PI) and A. González; Hospital Universitaria ‘Gregorio Marañon’ (Madrid): P. Miralles (PI) and T. Aldámiz‐Echevarría. Spain:
Publisher Copyright:
© 2020 British HIV Association
ID: 270555357